127 related articles for article (PubMed ID: 38215567)
1. Mismatch negativity and polygenic risk scores for schizophrenia and bipolar disorder.
Pentz AB; O'Connel KS; van Jole O; Timpe CMF; Slapø NB; Melle I; Lagerberg TV; Steen NE; Westlye LT; Haukvik UK; Moberget T; Jönsson EG; Andreassen OA; Elvsåshagen T
Schizophr Res; 2024 Feb; 264():314-326. PubMed ID: 38215567
[TBL] [Abstract][Full Text] [Related]
2. Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity.
Pentz AB; Timpe CMF; Normann EM; Slapø NB; Melle I; Lagerberg TV; Steen NE; Westlye LT; Jönsson EG; Haukvik UK; Moberget T; Andreassen OA; Elvsåshagen T
Schizophr Res; 2023 Nov; 261():80-93. PubMed ID: 37716205
[TBL] [Abstract][Full Text] [Related]
3. Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm.
McCleery A; Mathalon DH; Wynn JK; Roach BJ; Hellemann GS; Marder SR; Green MF
Psychol Med; 2019 May; 49(7):1195-1206. PubMed ID: 30642411
[TBL] [Abstract][Full Text] [Related]
4. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
[TBL] [Abstract][Full Text] [Related]
5. Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study.
Rodriguez V; Alameda L; Quattrone D; Tripoli G; Gayer-Anderson C; Spinazzola E; Trotta G; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; Bonora E; Jamain S; Selten JP; Velthorst E; de Haan L; Llorca PM; Arrojo M; Bobes J; Bernardo M; Arango C; Kirkbride J; Jones PB; Rutten BP; Richards A; Sham PC; O'Donovan M; Van Os J; Morgan C; Di Forti M; Murray RM; Vassos E
Psychol Med; 2023 Jun; 53(8):3396-3405. PubMed ID: 35076361
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder.
Ohi K; Shimada M; Soda M; Nishizawa D; Fujikane D; Takai K; Kuramitsu A; Muto Y; Sugiyama S; Hasegawa J; Kitaichi K; Ikeda K; Shioiri T
BMJ Ment Health; 2024 Jan; 27(1):. PubMed ID: 38216218
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
[TBL] [Abstract][Full Text] [Related]
8. Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder.
Allardyce J; Leonenko G; Hamshere M; Pardiñas AF; Forty L; Knott S; Gordon-Smith K; Porteous DJ; Haywood C; Di Florio A; Jones L; McIntosh AM; Owen MJ; Holmans P; Walters JTR; Craddock N; Jones I; O'Donovan MC; Escott-Price V
JAMA Psychiatry; 2018 Jan; 75(1):28-35. PubMed ID: 29167880
[TBL] [Abstract][Full Text] [Related]
9. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
[TBL] [Abstract][Full Text] [Related]
10. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
[TBL] [Abstract][Full Text] [Related]
11. Associations of mismatch negativity with psychotic symptoms and functioning transdiagnostically across psychotic disorders.
Donaldson KR; Novak KD; Foti D; Marder M; Perlman G; Kotov R; Mohanty A
J Abnorm Psychol; 2020 Aug; 129(6):570-580. PubMed ID: 32757601
[TBL] [Abstract][Full Text] [Related]
12. Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
Musliner KL; Krebs MD; Albiñana C; Vilhjalmsson B; Agerbo E; Zandi PP; Hougaard DM; Nordentoft M; Børglum AD; Werge T; Mortensen PB; Østergaard SD
Am J Psychiatry; 2020 Oct; 177(10):936-943. PubMed ID: 32660297
[TBL] [Abstract][Full Text] [Related]
13. Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.
Ohi K; Nishizawa D; Shimada T; Kataoka Y; Hasegawa J; Shioiri T; Kawasaki Y; Hashimoto R; Ikeda K
Int J Neuropsychopharmacol; 2020 Apr; 23(3):157-164. PubMed ID: 31900488
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases.
Charney AW; Stahl EA; Green EK; Chen CY; Moran JL; Chambert K; Belliveau RA; Forty L; Gordon-Smith K; Lee PH; Bromet EJ; Buckley PF; Escamilla MA; Fanous AH; Fochtmann LJ; Lehrer DS; Malaspina D; Marder SR; Morley CP; Nicolini H; Perkins DO; Rakofsky JJ; Rapaport MH; Medeiros H; Sobell JL; Backlund L; Bergen SE; Juréus A; Schalling M; Lichtenstein P; Knowles JA; Burdick KE; Jones I; Jones LA; Hultman CM; Perlis R; Purcell SM; McCarroll SA; Pato CN; Pato MT; Di Florio A; Craddock N; Landén M; Smoller JW; Ruderfer DM; Sklar P
Biol Psychiatry; 2019 Jul; 86(2):110-119. PubMed ID: 30686506
[TBL] [Abstract][Full Text] [Related]
15. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis.
Fryer SL; Roach BJ; Hamilton HK; Bachman P; Belger A; Carrión RE; Duncan E; Johannesen J; Light GA; Niznikiewicz M; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman L; Tsuang M; Walker EF; Woods SW; Mathalon DH
J Abnorm Psychol; 2020 Aug; 129(6):599-611. PubMed ID: 32757603
[TBL] [Abstract][Full Text] [Related]
16. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.
;
Cell; 2018 Jun; 173(7):1705-1715.e16. PubMed ID: 29906448
[TBL] [Abstract][Full Text] [Related]
17. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.
Schubert KO; Thalamuthu A; Amare AT; Frank J; Streit F; Adl M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cearns M; Cervantes P; Chen HC; Chillotti C; Cichon S; Clark SR; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Degenhardt F; Del Zompo M; DePaulo JR; Étain B; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Heilbronner U; Herms S; Hoffmann P; Hou L; Hsu YH; Jamain S; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Maj M; ; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Papiol S; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shekhtman T; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Tekola-Ayele F; Tortorella A; Turecki G; Veeh J; Vieta E; Witt SH; Roberts G; Zandi PP; Alda M; Bauer M; McMahon FJ; Mitchell PB; Schulze TG; Rietschel M; Baune BT
Transl Psychiatry; 2021 Nov; 11(1):606. PubMed ID: 34845190
[TBL] [Abstract][Full Text] [Related]
18. Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects.
Ohi K; Nishizawa D; Sugiyama S; Takai K; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
Int J Neuropsychopharmacol; 2021 Jul; 24(7):562-569. PubMed ID: 33738471
[TBL] [Abstract][Full Text] [Related]
19. Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?
Hermens DF; Chitty KM; Kaur M
Schizophr Res; 2018 Jan; 191():132-139. PubMed ID: 28450056
[TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.
Richards AL; Pardiñas AF; Frizzati A; Tansey KE; Lynham AJ; Holmans P; Legge SE; Savage JE; Agartz I; Andreassen OA; Blokland GAM; Corvin A; Cosgrove D; Degenhardt F; Djurovic S; Espeseth T; Ferraro L; Gayer-Anderson C; Giegling I; van Haren NE; Hartmann AM; Hubert JJ; Jönsson EG; Konte B; Lennertz L; Olde Loohuis LM; Melle I; Morgan C; Morris DW; Murray RM; Nyman H; Ophoff RA; ; van Os J; ; ; Petryshen TL; Quattrone D; Rietschel M; Rujescu D; Rutten BPF; Streit F; Strohmaier J; Sullivan PF; Sundet K; Wagner M; Escott-Price V; Owen MJ; Donohoe G; O'Donovan MC; Walters JTR
Schizophr Bull; 2020 Feb; 46(2):336-344. PubMed ID: 31206164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
